Carregant...
Development and validation of a high‐sensitivity assay for measuring p217+tau in plasma
INTRODUCTION: Diagnosis of Alzheimer's disease (AD) based on amyloid beta (A), pathologic tau (T), and neurodegeneration (N) biomarkers in peripheral fluids promises to accelerate clinical trials and intercept disease earlier. METHODS: Qualification of a Simoa plasma p217+tau assay was performe...
Guardat en:
| Publicat a: | Alzheimers Dement (Amst) |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8158165/ https://ncbi.nlm.nih.gov/pubmed/34095436 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dad2.12204 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|